Read + Share
Amedeo Smart
Independent Medical Education
. Initial high-efficacy disease-modifying therapy in multiple sclerosis: A nationwide cohort study. Neurology 2022 Oct 28. pii: WNL.0000000000201391.PMID: 36307223
Email
LinkedIn
Facebook
Twitter
Privacy Policy